CONMED (CNMD) PT Lowered to $79 at Needham & Company

January 23, 2019 7:34 AM

Needham & Company analyst Mike Matson lowered the price target on CONMED (NASDAQ: CNMD) to $79.00 (from $86.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found